Eli Lilly (LLY)
(Delayed Data from NYSE)
$918.52 USD
-2.97 (-0.32%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $917.81 -0.71 (-0.08%) 7:58 PM ET
1-Strong Buy of 5 1
F Value F Growth D Momentum F VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Top 31% (79 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.19 | 2.05 | 9.99 |
Current Quarter Estimate | 4.53 | 37.63 | 61.00 |
Year Ago Quarter Estimate | 0.10 | 12.41 | 54.84 |
Next Quarter Estimate | 5.49 | 38.42 | 63.00 |
Next Year Estimate | 23.97 | 173.72 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 160.92 | 6.60 | 15.67 |
Next Year | 45.36 | 16.80 | 11.34 |
Last 5 Years | 3.60 | 2.90 | 8.10 |
Next 5 Years | 20.00 | 11.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 101.37 | 22.31 |
Price/Book (MRQ) | 64.23 | 5.89 |
Price/Cash Flow (MRFY) | 120.83 | 12.20 |
Dividend Yield | 0.56% | 2.13% |
Net Profit Margin (TTM) | 18.86% | 18.86% |
Return on Equity (TTM) | 67.52% | 34.56% |
Debt to Equity (MRQ) | 1.74 | 40.19 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.